A snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey
Abstract This multi-center point prevalence study evaluated children who were diagnosed as having coronavirus disease 2019 (COVID-19). On February 2nd, 2022, inpatients and outpatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were included in the study from 12 cities and 24 centers in Turkey. Of 8605 patients on February 2nd, 2022, in participating centers, 706 (8.2%) had COVID-19. The median age of the 706 patients was 92.50 months, 53.4% were female, and 76.7% were inpatients. The three most common symptoms of the patients with COVID-19 were fever (56.6%), cough (41.3%), and fatigue (27.5%). The three most common underlying chronic diseases (UCDs) were asthma (3.4%), neurologic disorders (3.3%), and obesity (2.6%). The SARS-CoV-2-related pneumoniae rate was 10.7%. The COVID-19 vaccination rate was 12.5% in all patients. Among patients aged over 12 years with access to the vaccine given by the Republic of Turkey Ministry of Health, the vaccination rate was 38.7%. Patients with UCDs presented with dyspnea and pneumoniae more frequently than those without UCDs (p < 0.001 for both). The rates of fever, diarrhea, and pneumoniae were higher in patients without COVID-19 vaccinations (p = 0.001, p = 0.012, and p = 0.027). Conclusion: To lessen the effects of the disease, all eligible children should receive the COVID-19 vaccine. The illness may specifically endanger children with UCDs.What is Known:• Children with COVID-19 mainly present with fever and cough, as in adults.• COVID-19 may specifically threaten children with underlying chronic diseases.What is New:• Children with obesity have a higher vaccination rate against COVID-19 than children without obesity.• Among unvaccinated children, fever and pneumoniae might be seen at a higher ratio than among vaccinated children..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:182 |
|---|---|
| Enthalten in: |
European journal of pediatrics - 182(2023), 7 vom: 04. Mai, Seite 3231-3242 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yılmaz, Dilek [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
COVID-19 |
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s00431-023-04982-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2144526052 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2144526052 | ||
| 003 | DE-627 | ||
| 005 | 20240405160510.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240118s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00431-023-04982-6 |2 doi | |
| 035 | |a (DE-627)OLC2144526052 | ||
| 035 | |a (DE-He213)s00431-023-04982-6-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.67 |2 bkl | ||
| 100 | 1 | |a Yılmaz, Dilek |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Abstract This multi-center point prevalence study evaluated children who were diagnosed as having coronavirus disease 2019 (COVID-19). On February 2nd, 2022, inpatients and outpatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were included in the study from 12 cities and 24 centers in Turkey. Of 8605 patients on February 2nd, 2022, in participating centers, 706 (8.2%) had COVID-19. The median age of the 706 patients was 92.50 months, 53.4% were female, and 76.7% were inpatients. The three most common symptoms of the patients with COVID-19 were fever (56.6%), cough (41.3%), and fatigue (27.5%). The three most common underlying chronic diseases (UCDs) were asthma (3.4%), neurologic disorders (3.3%), and obesity (2.6%). The SARS-CoV-2-related pneumoniae rate was 10.7%. The COVID-19 vaccination rate was 12.5% in all patients. Among patients aged over 12 years with access to the vaccine given by the Republic of Turkey Ministry of Health, the vaccination rate was 38.7%. Patients with UCDs presented with dyspnea and pneumoniae more frequently than those without UCDs (p < 0.001 for both). The rates of fever, diarrhea, and pneumoniae were higher in patients without COVID-19 vaccinations (p = 0.001, p = 0.012, and p = 0.027). Conclusion: To lessen the effects of the disease, all eligible children should receive the COVID-19 vaccine. The illness may specifically endanger children with UCDs.What is Known:• Children with COVID-19 mainly present with fever and cough, as in adults.• COVID-19 may specifically threaten children with underlying chronic diseases.What is New:• Children with obesity have a higher vaccination rate against COVID-19 than children without obesity.• Among unvaccinated children, fever and pneumoniae might be seen at a higher ratio than among vaccinated children. | ||
| 650 | 4 | |a Children | |
| 650 | 4 | |a Clinical presentation | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Multi-center study | |
| 650 | 4 | |a Point prevalence study | |
| 700 | 1 | |a Üstündağ, Gülnihan |0 (orcid)0000-0002-6217-1927 |4 aut | |
| 700 | 1 | |a Büyükçam, Ayşe |4 aut | |
| 700 | 1 | |a Salı, Enes |4 aut | |
| 700 | 1 | |a Çelik, Ümit |4 aut | |
| 700 | 1 | |a Avcu, Gülhadiye |4 aut | |
| 700 | 1 | |a Belet, Nurşen |4 aut | |
| 700 | 1 | |a Çakmak Taşkın, Esra |4 aut | |
| 700 | 1 | |a Öcal Demir, Sevliya |4 aut | |
| 700 | 1 | |a Birbilen, Ahmet Ziya |4 aut | |
| 700 | 1 | |a Kılıç, Ömer |4 aut | |
| 700 | 1 | |a Metin Akcan, Özge |4 aut | |
| 700 | 1 | |a Tekin Yılmaz, Ayşe |4 aut | |
| 700 | 1 | |a Aldemir Kocabaş, Bilge |4 aut | |
| 700 | 1 | |a Hatipoğlu, Nevin |4 aut | |
| 700 | 1 | |a Karbuz, Adem |4 aut | |
| 700 | 1 | |a Çakır, Deniz |4 aut | |
| 700 | 1 | |a Sütçü, Murat |4 aut | |
| 700 | 1 | |a Aygün, Fatma Deniz |4 aut | |
| 700 | 1 | |a Çelik, Taylan |4 aut | |
| 700 | 1 | |a Bayturan Şen, Semra |4 aut | |
| 700 | 1 | |a Dalgıç, Nazan |4 aut | |
| 700 | 1 | |a Ümit, Zühal |4 aut | |
| 700 | 1 | |a Kara, Soner Sertan |4 aut | |
| 700 | 1 | |a Karadağ Öncel, Eda |4 aut | |
| 700 | 1 | |a Bolat, Ahmet |4 aut | |
| 700 | 1 | |a Kılıç Çil, Merve |4 aut | |
| 700 | 1 | |a Turan, Caner |4 aut | |
| 700 | 1 | |a Çakıl Güzin, Ayşe |4 aut | |
| 700 | 1 | |a Topal, Sevgi |4 aut | |
| 700 | 1 | |a Esen Besli, Gülser |4 aut | |
| 700 | 1 | |a Doğan, Gizem |4 aut | |
| 700 | 1 | |a Şahin, Sabiha |4 aut | |
| 700 | 1 | |a Akın, Fatih |4 aut | |
| 700 | 1 | |a Bildirici, Yaşar |4 aut | |
| 700 | 1 | |a Timurtaş Dayar, Gülperi |4 aut | |
| 700 | 1 | |a Ergül Sarı, Emine |4 aut | |
| 700 | 1 | |a Kızmaz İşançlı, Didem |4 aut | |
| 700 | 1 | |a Kara, Manolya |4 aut | |
| 700 | 1 | |a Önal, Pınar |4 aut | |
| 700 | 1 | |a Aylaç, Hakan |4 aut | |
| 700 | 1 | |a Lüleci, Duygu |4 aut | |
| 700 | 1 | |a Yaşar, Belma |4 aut | |
| 700 | 1 | |a Dede, Elif |4 aut | |
| 700 | 1 | |a Çağlar, Aykut |4 aut | |
| 700 | 1 | |a Akova, Sevgi |4 aut | |
| 700 | 1 | |a Afat Turgut, Elif |4 aut | |
| 700 | 1 | |a Yazıcı Özkaya, Pınar |4 aut | |
| 700 | 1 | |a Kandemir Gülmez, Tuğba |4 aut | |
| 700 | 1 | |a Ulusoy, Emel |4 aut | |
| 700 | 1 | |a Duyu, Muhterem |4 aut | |
| 700 | 1 | |a Kara, Yalçın |4 aut | |
| 700 | 1 | |a Çeliktaş, Hüseyin |4 aut | |
| 700 | 1 | |a Tekeli, Onur |4 aut | |
| 700 | 1 | |a Çağlar, Fatma |4 aut | |
| 700 | 1 | |a Gül, Doruk |4 aut | |
| 700 | 1 | |a Oral Cebeci, Sinem |4 aut | |
| 700 | 1 | |a Battal, Fatih |4 aut | |
| 700 | 1 | |a Bal, Alkan |4 aut | |
| 700 | 1 | |a Aygün, Emre |4 aut | |
| 700 | 1 | |a Uysalol, Metin |4 aut | |
| 700 | 1 | |a Arslan, Gazi |4 aut | |
| 700 | 1 | |a Özkavaklı, Ayberk |4 aut | |
| 700 | 1 | |a Kızıl, Mahmut Can |4 aut | |
| 700 | 1 | |a Yazar, Abdullah |4 aut | |
| 700 | 1 | |a Aygün, Fatih |4 aut | |
| 700 | 1 | |a Somer, Ayper |4 aut | |
| 700 | 1 | |a Kuyucu, Necdet |4 aut | |
| 700 | 1 | |a Dinleyici, Ener Çağrı |4 aut | |
| 700 | 1 | |a Kara, Ateş |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of pediatrics |d Springer Berlin Heidelberg, 1975 |g 182(2023), 7 vom: 04. Mai, Seite 3231-3242 |h Online-Ressource |w (DE-627)684135361 |w (DE-600)2647723-3 |w (DE-576)367395959 |x 1432-1076 |7 nnns |
| 773 | 1 | 8 | |g volume:182 |g year:2023 |g number:7 |g day:04 |g month:05 |g pages:3231-3242 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00431-023-04982-6 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_32 | ||
| 912 | |a GBV_ILN_39 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_90 | ||
| 912 | |a GBV_ILN_95 | ||
| 912 | |a GBV_ILN_100 | ||
| 912 | |a GBV_ILN_101 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_120 | ||
| 912 | |a GBV_ILN_138 | ||
| 912 | |a GBV_ILN_150 | ||
| 912 | |a GBV_ILN_151 | ||
| 912 | |a GBV_ILN_152 | ||
| 912 | |a GBV_ILN_161 | ||
| 912 | |a GBV_ILN_170 | ||
| 912 | |a GBV_ILN_171 | ||
| 912 | |a GBV_ILN_187 | ||
| 912 | |a GBV_ILN_213 | ||
| 912 | |a GBV_ILN_224 | ||
| 912 | |a GBV_ILN_230 | ||
| 912 | |a GBV_ILN_250 | ||
| 912 | |a GBV_ILN_281 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_370 | ||
| 912 | |a GBV_ILN_602 | ||
| 912 | |a GBV_ILN_636 | ||
| 912 | |a GBV_ILN_702 | ||
| 912 | |a GBV_ILN_2001 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2007 | ||
| 912 | |a GBV_ILN_2008 | ||
| 912 | |a GBV_ILN_2009 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a GBV_ILN_2011 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a GBV_ILN_2015 | ||
| 912 | |a GBV_ILN_2020 | ||
| 912 | |a GBV_ILN_2021 | ||
| 912 | |a GBV_ILN_2025 | ||
| 912 | |a GBV_ILN_2026 | ||
| 912 | |a GBV_ILN_2027 | ||
| 912 | |a GBV_ILN_2031 | ||
| 912 | |a GBV_ILN_2034 | ||
| 912 | |a GBV_ILN_2037 | ||
| 912 | |a GBV_ILN_2038 | ||
| 912 | |a GBV_ILN_2039 | ||
| 912 | |a GBV_ILN_2044 | ||
| 912 | |a GBV_ILN_2048 | ||
| 912 | |a GBV_ILN_2049 | ||
| 912 | |a GBV_ILN_2050 | ||
| 912 | |a GBV_ILN_2055 | ||
| 912 | |a GBV_ILN_2057 | ||
| 912 | |a GBV_ILN_2059 | ||
| 912 | |a GBV_ILN_2061 | ||
| 912 | |a GBV_ILN_2064 | ||
| 912 | |a GBV_ILN_2065 | ||
| 912 | |a GBV_ILN_2068 | ||
| 912 | |a GBV_ILN_2088 | ||
| 912 | |a GBV_ILN_2093 | ||
| 912 | |a GBV_ILN_2106 | ||
| 912 | |a GBV_ILN_2107 | ||
| 912 | |a GBV_ILN_2108 | ||
| 912 | |a GBV_ILN_2110 | ||
| 912 | |a GBV_ILN_2111 | ||
| 912 | |a GBV_ILN_2112 | ||
| 912 | |a GBV_ILN_2113 | ||
| 912 | |a GBV_ILN_2118 | ||
| 912 | |a GBV_ILN_2122 | ||
| 912 | |a GBV_ILN_2129 | ||
| 912 | |a GBV_ILN_2143 | ||
| 912 | |a GBV_ILN_2144 | ||
| 912 | |a GBV_ILN_2147 | ||
| 912 | |a GBV_ILN_2148 | ||
| 912 | |a GBV_ILN_2152 | ||
| 912 | |a GBV_ILN_2153 | ||
| 912 | |a GBV_ILN_2188 | ||
| 912 | |a GBV_ILN_2190 | ||
| 912 | |a GBV_ILN_2232 | ||
| 912 | |a GBV_ILN_2336 | ||
| 912 | |a GBV_ILN_2446 | ||
| 912 | |a GBV_ILN_2470 | ||
| 912 | |a GBV_ILN_2472 | ||
| 912 | |a GBV_ILN_2474 | ||
| 912 | |a GBV_ILN_2507 | ||
| 912 | |a GBV_ILN_2522 | ||
| 912 | |a GBV_ILN_2548 | ||
| 912 | |a GBV_ILN_4035 | ||
| 912 | |a GBV_ILN_4037 | ||
| 912 | |a GBV_ILN_4046 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4242 | ||
| 912 | |a GBV_ILN_4246 | ||
| 912 | |a GBV_ILN_4249 | ||
| 912 | |a GBV_ILN_4251 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_4322 | ||
| 912 | |a GBV_ILN_4323 | ||
| 912 | |a GBV_ILN_4324 | ||
| 912 | |a GBV_ILN_4325 | ||
| 912 | |a GBV_ILN_4326 | ||
| 912 | |a GBV_ILN_4328 | ||
| 912 | |a GBV_ILN_4333 | ||
| 912 | |a GBV_ILN_4334 | ||
| 912 | |a GBV_ILN_4335 | ||
| 912 | |a GBV_ILN_4336 | ||
| 912 | |a GBV_ILN_4338 | ||
| 912 | |a GBV_ILN_4393 | ||
| 912 | |a GBV_ILN_4700 | ||
| 936 | b | k | |a 44.67 |j Kinderheilkunde |j Kinderheilkunde |q VZ |
| 951 | |a AR | ||
| 952 | |d 182 |j 2023 |e 7 |b 04 |c 05 |h 3231-3242 | ||